<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04611204</url>
  </required_header>
  <id_info>
    <org_study_id>RC31/18/0470</org_study_id>
    <nct_id>NCT04611204</nct_id>
  </id_info>
  <brief_title>Prevalence of Transthyretin Cardiac Amyloidosis in Patients With Idiopathic Carpal Tunnel Syndrome Referred for Release Surgery</brief_title>
  <acronym>PRATHYC</acronym>
  <official_title>Prevalence of Transthyretin Cardiac Amyloidosis in Patients With Idiopathic Carpal Tunnel Syndrome Referred for Release Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Toulouse</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Toulouse</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will determine the prevalence of transthyretin amyloidosis in pathology of the&#xD;
      transverse carpal ligament and cardiac involvement using natriuretic peptides,&#xD;
      electrocardiography and echocardiography in patients referred for carpal tunnel release&#xD;
      surgery of idiopathic carpal tunnel syndrome. This study will describe the relationship&#xD;
      between amyloid deposition observed on the transverse carpal ligament and the presence of&#xD;
      cardiac involvement.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Unrecognized wild-type transthyretin amyloidosis (ATTRwt) in patients with idiopathic carpal&#xD;
      tunnel syndrome (CTS) is a prevalent aging-related disorder. Amyloid deposition in the&#xD;
      tenosynovial tissue has been reported in ~35% of patients with idiopathic carpal tunnel&#xD;
      syndrome.&#xD;
&#xD;
      Otherwise, CTS has been shown to be the most common initial symptom of systemic wild-type&#xD;
      transthyretin amyloidosis. The clinical significance of subclinical ATTRwt deposits in the&#xD;
      heart in elderly patients has yet to be determined, but these deposits could contribute to&#xD;
      the development of heart failure with preserved ejection fraction. ATTRwt has been reported&#xD;
      in ~15% of patients with heart failure with preserved ejection fraction. Early detection of&#xD;
      amyloid deposition in the transverse carpal ligament of patients with CTS could anticipate&#xD;
      cardiac damage and progression to heart failure.The aim of this study is to determine the&#xD;
      prevalence of transthyretin amyloidosis in pathology of the transverse carpal ligament and&#xD;
      cardiac involvement using natriuretic peptides, electrocardiography and echocardiography in&#xD;
      patients referred for carpal tunnel release surgery of idiopathic carpal tunnel syndrome.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2020</start_date>
  <completion_date type="Anticipated">April 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiac involvement</measure>
    <time_frame>1 day</time_frame>
    <description>Prevalence of cardiac involvement in presence of transthyretin amyloid deposition in the transverse carpal ligament of patients with CTS referred for surgery released.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Transthyretin amyloid involvement</measure>
    <time_frame>1 day</time_frame>
    <description>Prevalence of transthyretin amyloid deposition in the transverse carpal ligament of patients with CTS referred for surgery released. Electrocardiographic features of cardiac involvement in case of presence of transthyretin amyloid deposition in the transverse carpal ligament of patients with CTS referred for surgery released.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Transthyretin Amyloidosis</condition>
  <condition>Carpal Tunnel Syndrome</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Descriptive cohort</intervention_name>
    <description>NT-proBNP assay, electrocardiogram and transthoracic echocardiography before CTS surgery release. Pathological analysis for amyloid deposits of transverse carpal ligament of patients included.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Interventional transversal monocentric study with prospective recruitment.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients over 18 year-old&#xD;
&#xD;
          -  Indication carpal tunnel release surgery of idiopathic carpal tunnel syndrome.&#xD;
&#xD;
          -  To agree to participate (signature of the informed consent)&#xD;
&#xD;
          -  Affiliate or beneficiary of a social security scheme&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with non-idiopathic carpal tunnel syndrome with medical contraindication :&#xD;
             pregnancy, obesity (body mass index &gt; 30), diabetes, rheumatoid arthritis,&#xD;
             sarcoidosis, purulent tenosynovitis, tuberculosis, systemic lupus erythematosus,&#xD;
             hypothyroidism or hyperthyroidism and gout.&#xD;
&#xD;
          -  Patients with history of cardiac disease or coronary artery disease.&#xD;
&#xD;
          -  Patients with systemic amyloidosis already known.&#xD;
&#xD;
          -  Patients unde guardianship or curatorship&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Olivier Lairez</last_name>
    <phone>5 61 32 28 73</phone>
    <phone_ext>+33</phone_ext>
    <email>lairez.o@chu-toulouse.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Olivier Lairez</name>
      <address>
        <city>Toulouse</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Audrey Tomasik</last_name>
      <phone>5 61 77 85 97</phone>
      <phone_ext>+33</phone_ext>
      <email>tomasik.a@chu-toulouse.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 26, 2020</study_first_submitted>
  <study_first_submitted_qc>October 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 2, 2020</study_first_posted>
  <last_update_submitted>October 26, 2020</last_update_submitted>
  <last_update_submitted_qc>October 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cardiac amyloidosis</keyword>
  <keyword>transthyretin amyloidosis</keyword>
  <keyword>carpal tunnel syndrome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carpal Tunnel Syndrome</mesh_term>
    <mesh_term>Amyloidosis</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

